Articles tagged with Bone Diseases
A University of Virginia engineer developed a workflow to combine advanced imaging technologies for improved understanding of porous bone, which could inform disease detection. The method allows for three-dimensional rendering of bone structure across various length scales.
Researchers at Aston University have created a potential treatment for bone cancer using gallium-doped bioactive glasses, which has shown a 99% success rate in killing osteosarcoma cells. The therapy also promotes early stages of bone formation and regenerates diseased bones.
Research at the University of Tsukuba found high vertebral instability and diffuse low-signal changes in T2-weighted MRI observations to be risk factors for deteriorated ambulation status following different conservative treatments. These findings could help predict whether a patient's ability to walk will be affected by these treatments.
The International Space Station National Laboratory is collaborating with NASA to fund up to $4 million in research addressing significant diseases like cancer, cardiovascular disease, and neurodegenerative disease. The joint solicitation aims to leverage microgravity to improve existing or develop new technologies for health problems ...
Researchers found a significant association between the KIT M541L variant and mastocytosis diagnosis in patients with systemic and cutaneous mastocytosis. The variant was identified in 19 individuals, mostly diagnosed with systemic mastocytosis, but without significant differences in symptomatology.
A new position paper argues that single race-agnostic FRAX models would unfairly discriminate against Black, Asian, and Hispanic communities. The authors recommend retention of ethnic and race-specific FRAX models for the US with updated data on fracture and death hazards.
A new study from the University of Toledo found that individuals with diabetes are nearly three times more likely to experience non-union complications following spinal fusion surgery. Researchers also found that diabetic patients have weaker bone growth and healing, leading to increased degeneration in adjacent segments of the spine.
A research team from Osaka University identified a key osteoporosis-related gene, Men1, and developed a new animal model of the disease. The study found that inactivation of Men1 led to cellular senescence in osteoblasts, reducing bone formation activity and increasing bone resorption.
Researchers identify key proteins and signaling pathways for personalized treatment, enabling early detection of aggressive tumors. The study provides a crucial resource for developing new therapies and tests to guide treatment.
Researchers explore the feasibility of deep learning models in segmenting lesions on PET/CT images to improve salvage radiation therapy planning for prostate cancer. The study demonstrates promising potential to reduce inter- and intra-observer variations, leading to more accurate treatment outcomes.
A new Europe-wide clinical framework aims to collect high-quality biological samples from patients, enabling researchers and clinicians to understand the genetic, biological, and other factors involved in childhood bone cancer. This will guide the development of tailored treatments for each patient's cancer type.
A new global definition of sarcopenia is proposed, aiming to unify research and clinical practice. The definition may help identify low muscle mass or strength in older people, increasing the risk of poor outcomes such as fragility and disability.
A yearlong randomized controlled trial found that daily prune consumption slowed bone loss connected to osteoporosis. Participants who ate at least four to six prunes every day maintained bone density and bone strength.
The IOF position paper emphasizes the need for population-specific vitamin D approaches, considering factors like diet, skin pigmentation, and supplement use. The authors also highlight the importance of standardized measures of 25(OH)D in future studies.
Research presented at ENDO 2024 found that older women with low bone density are more likely to experience their first hip fracture in their 60s. A study analyzing NHANES data revealed a significant increase in osteoporosis, but surprisingly, a decrease in fragility hip fractures between 60-70 years.
A new study reveals how accumulation of IMAT drives diseases such as muscle loss, type 2 diabetes, and cardiovascular disease. Regular exercise and healthy diet can prevent and reverse IMAT accumulation.
Dr. Melissa Grunlan's team creates regenerative osteochondral plugs, a potential off-the-shelf device to treat OCDs and avoid total knee replacement surgery. The technology offers an alternative to autografting or total knee replacement, providing immediate support for joint function and potentially reducing post-operative complications.
A genomic study uncovers germline ARID1B and mitochondrial variants that may drive pediatric chordoma genesis, a rare and aggressive bone tumor. The study found aberrant indels and haywire mitochondria in 22% of pediatric chordoma samples.
Researchers discovered a link between high arm fat and low bone quality, particularly in the spine. Those with excess body fat, regardless of BMI, had lower bone quality and strength in their vertebrae.
The 5-year TAF treatment efficacy was high and similar to that of 3-year TDF followed by 2-year TAF in Chinese chronic hepatitis B patients. Favorable effects on bone and renal parameters were sustained with TAF treatment alone and were observed following the switch from TDF to TAF.
Researchers at NeuRA and UniSA found that early detection and comprehensive treatment can lead to significant recovery for most people with Complex Regional Pain Syndrome (CRPS) within 12-18 months. The study reviews the latest advances in CRPS epidemiology, pathophysiology, diagnosis, and treatment.
The International Osteoporosis Foundation (IOF) and ESCEO presented awards to 20 young investigators from 16 countries for their outstanding research abstracts. The awards recognize the researchers' contributions to the prevention, diagnosis, and treatment of osteoporosis and related musculoskeletal diseases.
Professor Leith Zakraoui was awarded the 2024 IOF CNS Medal for his dedicated work in advancing musculoskeletal health at both national and international levels. He has been a key figure in strengthening IOF activities in Africa and promoting education and awareness within the region.
The International Osteoporosis Foundation has presented the prestigious IOF President’s Award to Professor Peter Ebeling AO in recognition of his longstanding contributions to advancing the work of the IOF. He is an internationally renowned expert in bone health, with a total of over 536 peer-reviewed publications and a h-index of 93.
The World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases will showcase new clinical research from over 1507 submitted abstracts. The event will offer valuable knowledge to help clinicians treat patients more effectively in their daily practice.
A comprehensive review examines the impact of osteoporosis on fracture healing and the effects of osteoporosis medications. The study concludes that there is no deleterious effect of osteoporosis medications on fracture healing, and prompt treatment can reduce the risk of secondary fractures.
Long-term treatment with methylene blue (MB) and mitoquinone (MitoQ) did not alter age-related bone loss in mice. Antioxidant interventions are insufficient to inhibit skeletal aging, suggesting alternative approaches may be needed.
Researchers developed an AI model to detect viable tumor cells in osteosarcoma patients, improving prognosis predictions. The model showed comparable detection performance to pathologists and reduced inter-assessor variability, enabling timely assessment.
The International Osteoporosis Foundation and European Society for Clinical and Economic Aspects of Osteoporosis have issued new guidelines for managing osteoporosis in men. These recommendations cover disease burden, fracture risk assessment, treatment thresholds, and interventions to reduce the substantial morbidity and mortality ass...
Scientists discovered how water influences collagen formation and assembly. Replacing water with heavy water accelerates collagen production but results in a less stable network. The study's findings offer insights into collagen-related diseases like brittle bone disease and may lead to new materials with controlled mechanical properties.
A study by Dr. Yamamoto et al. discovered 200 types of proteins, including β2-m, adsorbed onto blood purification devices in dialysis patients. These proteins, such as lysozyme, are involved in amyloid fibril formation and may contribute to the disease progression.
A new study found that the link between paternal age and rare congenital disorders is more complex than previously thought. Researchers discovered that while older fathers are more likely to have children with certain bone and heart malformations, some genetic mutations associated with these conditions do not increase with paternal age.
A new study aims to develop a treatment for osteoarthritis by regenerating cartilage using nasal cartilage tissue. The method has already shown promising results in smaller studies, with the goal of providing an alternative to prostheses and improving patient outcomes.
Researchers at Mayo Clinic shed light on the biology of zombie cells and their link to aging-related health issues. A study found that specific senescent biomarkers can predict mortality beyond chronological age and chronic disease presence.
Researchers identify a promising prognostic biomarker for lung cancer using circulating tumor DNA-based minimal residual disease detection. The study found that this method can effectively guide treatment decisions and predict recurrence risk, potentially modifying the lung cancer treatment paradigm.
Researchers found significantly higher levels of IL-18 expression in osteoarthritis patients and cells compared to healthy controls. IL-17 promoted IL-18 production through the MEK/ERK/miR-4492 axis, indicating potential therapeutic targets for OA treatment.
Researchers found evidence of seasonal vitamin D deficiency in ancient teeth, indicating that latitude and sunlight exposure played a major role. The study's findings provide insight into how past populations developed the disease, shedding light on its history and potential causes.
A study published in PLOS ONE suggests that childhood vitamin D deficiency was widespread in industrialized England during the 18th and 19th centuries. Analysis of teeth from 25 individuals reveals a high incidence of VDD, with males affected more frequently than females, possibly related to social dynamics.
Researchers from Niigata University discovered a novel macrolide-DEL-1 axis that drives bone regeneration in aging individuals. The study found that macrolide-based molecules increase DEL-1 protein expression and promote new bone formation, suggesting a potential therapeutic avenue for periodontitis-induced bone loss in humans.
Researchers found that one in five adults reported difficulty walking a kilometre, and those with more limitations had significantly higher fracture risks. The study suggests asking about walking ability could help identify individuals needing further screening and prescribe interventions to prevent fractures.
Researchers found decreased BMAd density and altered distribution profile in MGUS patients who developed MM, indicating early changes in bone marrow adipose tissue. These findings suggest the potential for timely interventions and personalized treatment strategies.
Researchers have made a groundbreaking discovery linking a genetic defect in the MGP gene to autosomal dominant spondyloepiphyseal dysplasia, a rare skeletal disorder. The study highlights the importance of the MGP gene and its role in skeletal development, paving the way for potential therapeutic interventions.
Researchers discuss reductive carboxylation of glutamine as a potential target in acute myeloid leukemia (AML), an aggressive cancer with poor patient outcomes. The approach aims to weaken tumor cell survival mechanisms, potentially leading to novel therapies and improved patient outcomes.
This study found that SIRT6 activation improves DNA damage repair efficiency and reduces baseline DNA damage in chondrocytes from older donors. MDL-800 treatment also lowered p16 promoter activity and decreased DNA damage in murine cartilage explants, supporting the concept of SIRT6 as a critical regulator of DNA repair.
A new study has found that most patients with osteoporosis want to receive information on their fracture risk, but only half of them actually get it. Patients prefer visual representations, such as graphs with a colored traffic-light system, to communicate fracture risk and are more likely to take medication if presented in this way.
Researchers at University of Pittsburgh and KU Leuven identified 30 genetic regions associated with head shape, shedding light on the biological basis of craniosynostosis. The study also found that many genes play key roles in early head formation and bone development.
A team at Weill Cornell Medicine mapped the location and spatial features of blood-forming cells in human bone marrow, confirming hypotheses and providing a powerful new means to study diseases. The method, which uses artificial intelligence, identified and determined the positions of about 1.5 million cells in archival samples.
A pivotal trial of wearable treatment Osteoboost for osteopenia in post-menopausal women showed a significant reduction in vertebral bone strength loss. The study found an average bone strength loss of 0.48% in the Active Treatment group, compared to 2.84% in the Sham group.
Researchers at Queen Mary University of London developed a new organ-on-a-chip model of the human synovium to study arthritis mechanisms and develop new treatments. The three-dimensional microfluidic device successfully replicates key features of native synovium biology.
Researchers have developed STARVar, an artificial intelligence-powered method that leverages diverse data sources to identify genetic variants associated with diseases. The tool prioritizes genomic variants based on real-world patient symptoms, providing a more nuanced understanding of clinical presentations.
A study found that a water additive containing pomegranate extract can limit the formation of plaque and tartar in dogs after professional dental cleaning. The additive was shown to reduce plaque buildup by 47% and tartar by 24%, promoting healthy gums.
A phase 2 trial shows garetosmab significantly reduces new bone lesions and soft tissue flare-ups in FOP patients. The treatment also prevents the progression of the disease, giving hope to individuals affected by this rare condition.
Researchers developed a DNA damage-induced senescence model in osteoarthritic chondrocytes, which reliably induces cellular senescence and accumulates senescent cells in OA joint tissues. The study provides a useful model to develop therapeutic approaches targeting senescence in osteoarthritis.
A new type of bone-forming stem cell, DDR2+, has been found to cause premature skull fusion in infants. The researchers discovered that the abnormal proliferation of this stem cell leads to an excess of bone-making cells, resulting in craniosynostosis.
A new Australian study found that implementing simple bone-strengthening strategies throughout the community can lead to a substantial decrease in hip fractures. The study analyzed data from over 3000 individuals aged 60+ and showed a 45% decline in hip fractures despite only a 3% increase in bone mineral density.
The study aims to evaluate the efficacy of a synbiotic medical food, SBD111, in maintaining lumbar spine bone mineral density with aging. The researchers hope to provide new dietary interventions for preventing osteoporosis and fractures.
Researchers found stable antibodies in 800-year-old medieval human teeth that can still recognize viral proteins, allowing them to study the history of infectious human diseases. This discovery expands the field of palaeoproteomics and may enable experts to analyze how human antibody responses developed over time.
A new review describes the development and impact of a Latin American mentorship program for Fracture Liaison Services (FLS), resulting in 64 FLSs getting started and providing coverage for over 17,200 patients. The program also supports the establishment of active communities of mentors across Mexico, Brazil, Colombia, and Argentina.
The Capture the Fracture Partnership has successfully driven global Fracture Liaison Services implementation, effectiveness, and sustainability. The partnership's unique approach, including policy, coalitions, mentorship, and scalable solutions, has delivered impactful resources and activities to prioritize secondary fracture prevention.
A new position paper reviews TBS for fracture risk prediction, treatment initiation and monitoring in osteoporosis. The evidence-based guide provides practical guidance for clinicians to integrate TBS into clinical practice.